4.7 Article

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 214, Issue 4, Pages 607-611

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiw204

Keywords

anti-HIV agents; administration and dosage; adverse effects; HIV infections; drug therapy/virology; bone density

Funding

  1. NIAID [U01A1068636]
  2. National Institute of Mental Health (NIMH)
  3. National Institute of Dental and Craniofacial Research (NIDCR)
  4. NIH [K23AI108358, UM1AI069481, UM1AI069494, K23AG050260, R01AG020727, U01AI042590, K24AI120834]
  5. Gilead Sciences
  6. Viiv Healthcare
  7. NIAID
  8. Eunice Kennedy Shriver National Institute of Child Health and Human Development
  9. National Cancer Institute
  10. National Institute on Drug Abuse
  11. NIMH
  12. NIDCR
  13. National Institute on Alcohol Abuse and Alcoholism
  14. National Institute on Deafness and other Communication Disorders
  15. NIH Office of Research on Women's Health

Ask authors/readers for more resources

We compared adjusted bone mineral density (BMD) changes between human immunodeficiency virus (HIV)-infected individuals during the first approximately 7.5 years after antiretroviral therapy (ART) initiation and HIV-uninfected controls. HIV-infected individuals (n = 97) had significantly greater adjusted BMD decline than controls (n = 614) during the first 96 weeks of ART. Subsequently, the rate of BMD decline slowed in HIV-infected individuals but remained greater than the rate of decline in HIV-uninfected individuals at the lumbar spine but not at the hip. In HIV-infected individuals after 96 weeks, no HIV- or treatment-related characteristic was associated with BMD loss, but lower lean body mass was associated with greater BMD loss at both lumbar spine and hip.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient

Lawrence J. Purpura, Michelle Chang, Medini K. Annavajhala, Hiroshi Mohri, Lihong Liu, Jayesh Shah, Anyelina Cantos, Nicola Medrano, Justin Laracy, Brian Scully, Benjamin A. Miko, Marlena Habal, Marcus R. Pereira, Moriya Tsuji, David D. Ho, Anne-Catrin Uhlemann, Michael T. Yin

Summary: In immunosuppressed patients, the persistence of SARS-CoV-2 infection may be prolonged, leading to potential viral evolution. Immune response peaks around days 44-72 after diagnosis but wanes over time, allowing for increased viral genetic diversity and the emergence of variants.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Immunology

Regional Differences in Risk of Recurrent Falls Among Older US Women and Men with HIV in the HIV Infection, Aging, and Immune Function Long-Term Observational Study

Mona Abdo, Xingye Wu, Anjali Sharma, Katherine K. Tassiopoulos, Todd T. Brown, Susan L. Koletar, Michael T. Yin, Kristine M. Erlandson

Summary: Geographic location was a strong predictor of falls among older people with HIV, with differences in risk across regions. Associations between region and recurrent falls were found to be modified by physical activity and obesity status.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)

Article Health Policy & Services

Disclosure to South African children about their own HIV status over time

Melody Wu, Stephanie Shiau, Renate Strehlau, Afaaf Liberty, Faeezah Patel, Megan Burke, Pamela M. Murnane, Avy Violari, Michael T. Yin, Elaine J. Abrams, Louise Kuhn, Stephen Arpadi

Summary: This study assessed pediatric disclosure among CLHIV in South Africa and found that about 70.3% of the children were aware of their HIV status. Older age and a history of hunger were predictors of disclosure. Caregivers who had not yet disclosed may have been preparing to do so by discussing their child's health and HIV-related topics.

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2023)

Article Rehabilitation

Evaluation of submaximal endurance in young children living with HIV

Joanne Potterton, Renate Strehlau, Stephanie Shiau, Nicolette Comley-White, Louise Kuhn, Michael Yin, Stephen Arpadi

Summary: This study compared the sub-maximal endurance of children living with HIV (CLHIV) to a non-infected comparison group. The results showed that CLHIV who initiated antiretroviral therapy early with well-controlled disease were able to attain submaximal endurance levels similar to their uninfected peers.

SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY (2022)

Letter Immunology

Cytokines in HIV infection: authors' reply

Yanhan Shen, Stephanie Shiau, Michael T. Yin, Stephen M. Arpadi

Article Health Care Sciences & Services

Challenges and opportunities of telehealth digital equity to manage HIV and comorbidities for older persons living with HIV in New York State

Abigail Baim-Lance, Matthew Angulo, Mary Ann Chiasson, Helen-Maria Lekas, Rachel Schenkel, Jason Villarreal, Anyelina Cantos, Christine Kerr, Aarthi Nagaraja, Michael T. Yin, Peter Gordon

Summary: This mixed methods study investigated the digital equity, access, use, and quality of HIV and specialty telehealth services for older persons living with HIV (PLWH) during the initial wave of the COVID-19 pandemic. The study found that telehealth access and use were influenced by factors such as devices and connectivity, technology literacy, and comfort including privacy concerns. Participants perceived telehealth visits as less interpersonal and resulting in poorer outcomes compared to in-person visits, especially those with less formal education. The study highlights the need to establish equitable and desirable telehealth services for older PLWH.

BMC HEALTH SERVICES RESEARCH (2022)

Article Cell Biology

An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses

Lihong Liu, Sho Iketani, Yicheng Guo, Eswar R. Reddem, Ryan G. Casner, Manoj S. Nair, Jian Yu, Jasper F-W Chan, Maple Wang, Gabriele Cerutti, Zhiteng Li, Nicholas C. Morano, Candace D. Castagna, Laura Corredor, Hin Chu, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chun-Sing Chan, Zhiwei Chen, Yang Luo, Marcus Cunningham, Alejandro Chavez, Michael T. Yin, David S. Perlin, Moriya Tsuji, Kwok-Yung Yuen, Peter D. Kwong, Zizhang Sheng, Yaoxing Huang, Lawrence Shapiro, David D. Ho

Summary: This study identified a human monoclonal antibody, 10-40, that can neutralize or bind all tested sarbecoviruses and provide protection against SARS-CoV-2 and SARS-CoV in vivo. Comparative studies showed that 10-40 has the broadest effectiveness against sarbecoviruses among other receptor-binding domain (RBD)-directed antibodies, making it a promising candidate for pandemic preparedness. Structural analyses also revealed a conserved epitope cluster and a distinct antibody class with a common CDRH3 motif.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Pharmacology & Pharmacy

Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID-19 patients in New York City

Alex K. Lyashchenko, Yifan Yu, Donald J. McMahon, Robert Bies, Michael T. Yin, Serge Cremers

Summary: This study aimed to investigate the relationship between systemic exposure to hydroxychloroquine (HCQ) and its metabolite desethylhydroxychloroquine (DHCQ) and clinical outcome in severely ill COVID-19 patients. The results showed substantial variability in systemic exposure to HCQ and DHCQ, which was not clearly explained by renal or liver function or inflammatory state. Furthermore, systemic exposure did not correlate with intubation status, survival, or QTc prolongation. Therefore, this study adds to the growing body of evidence that oral HCQ does not alter the course of disease in COVID-19 patients.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Immunology

Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus

Brandilyn A. Peters, David B. Hanna, Anjali Sharma, Kathryn Anastos, Donald R. Hoover, Qiuhu Shi, Caitlin A. Moran, Elizabeth A. Jackson, Maria L. Alcaide, Igho Ofotokun, Adaora A. Adimora, Sabina A. Haberlen, Mardge Cohen, Phyllis C. Tien, Katherine G. Michel, Steven R. Levine, Howard N. Hodis, Robert C. Kaplan, Michael T. Yin

Summary: In this cohort study, ever use of estrogen-based hormone therapy was associated with less progression of subclinical atherosclerosis over time in women with and without HIV. This suggests that hormone therapy may confer a similar cardiovascular benefit for both groups.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Bone Quality in Relation to HIV and Antiretroviral Drugs

Arnold Z. Olali, Kelsey A. Carpenter, Maria Myers, Anjali Sharma, Michael T. Yin, Lena Al-Harthi, Ryan D. Ross

Summary: The available data suggests that bone quality deteriorates in people living with HIV. Future research is needed to determine the factors, such as the virus or ARVs, contributing to bone quality loss and which bone quality factors are most associated with increased fracture risk.

CURRENT HIV/AIDS REPORTS (2022)

Review Dentistry, Oral Surgery & Medicine

The Role of Oral Health in the Acquisition and Severity of SARS-CoV-2: A Retrospective Chart Review

S. Wadhwa, S. Dave, M. L. Daily, A. Nardone, R. Li, J. Rosario, A. Cantos, J. Shah, H. H. Lu, D. J. McMahon, M. T. Yin

Summary: This study investigates the association between oral health and COVID-19 acquisition and severity. The findings suggest that alveolar bone loss and missing teeth are positively associated with COVID-19 disease. Further research can be done to explore the underlying mechanisms of the impact of oral health on COVID-19.

SAUDI DENTAL JOURNAL (2022)

Editorial Material Public, Environmental & Occupational Health

The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation

Kathrine Meyers, Nadia Nguyen, Jason E. Zucker, Bryan A. Kutner, Caroline Carnevale, Delivette Castor, Magdalena E. Sobieszczyk, Michael T. Yin, Sarit A. Golub, Robert H. Remien

Summary: The long-acting integrase-inhibitor cabotegravir is highly effective in preventing HIV acquisition. However, its long drug tail poses challenges for safe discontinuation and potential drug resistance. Comprehensive patient education, training for healthcare teams, and adherence support strategies are suggested to overcome this challenge.

AIDS AND BEHAVIOR (2023)

Article Infectious Diseases

Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants

Lihong Liu, Kathrine Meyers, Lawrence J. Purpura, Nadia Nguyen, Hiroshi Mohri, Jennifer Y. Chang, Medini K. Annavajhala, Leo Lopez, Sang Won Lee, Jayesh Shah, Benjamin Lane, Anyelina Cantos, Sade A. Tukuru, Yicheng Guo, Kenra Ford, Yueh-Ting Chiu, Zizhang Sheng, Tenzin Choesang, Delivette Castor, Maple Wang, Christina Pili, Michael N. Van Hoy, Andrew Wallach, Jamie Horton, Zhiqiang Chen, Susan Rosenthal, Son McLaren, Baowei Jiang, Frank Wang, Helen H. Lu, Anne-Catrin Uhlemann, David D. Ho, Michael T. Yin

Summary: The development of a rapid antigen test using two pairs of monoclonal antibodies has resulted in a high-performing test that remains effective across multiple variants in both laboratory and clinical evaluations. The test is capable of identifying almost all individuals carrying infectious SARS-CoV-2.

JOURNAL OF CLINICAL VIROLOGY PLUS (2022)

Article Multidisciplinary Sciences

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Sho Iketani, Lihong Liu, Yicheng Guo, Liyuan Liu, Jasper F-W Chan, Yiming Huang, Maple Wang, Yang Luo, Jian Yu, Hin Chu, Kenn K-H Chik, Terrence T-T Yuent, Michael T. Yin, Magdalena E. Sobieszczyk, Yaoxing Huang, Kwok-Yung Yuen, Harris H. Wang, Zizhang Sheng, David D. Ho

Summary: The identification of the Omicron variant of SARS-CoV-2 in Botswana in November 2021 sparked concern due to the spike protein alterations that could potentially evade antibodies. Further studies showed that the Omicron sublineages, BA.1+R346K and BA.2, are antigenically similar to the wild-type virus and pose similar risks to the effectiveness of current vaccines. BA.2 also demonstrated resistance to many neutralizing monoclonal antibodies, highlighting the challenges in developing effective therapeutic options.

NATURE (2022)

Article Immunology

SARS-CoV-2 RNA Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection

Lawrence J. Purpura, Joseph Alukal, Alexander M. Chong, Lihong Liu, Anyelina Cantos, Jayesh Shah, Nicola Medrano, Jennifer Y. Chang, Moriya Tsuji, Hiroshi Mohri, Anne Catrin Uhlemann, David Ho, Michael T. Yin

Summary: We detected severe acute respiratory syndrome coronavirus 2 in semen during the late convalescent phase, indicating the potential presence of the virus in the immune-privileged testes.

EMERGING INFECTIOUS DISEASES (2022)

No Data Available